Addressing some of the most persistent global health burdens, parasitic vaccines aim to prevent diseases like malaria, leishmaniasis, and schistosomiasis. Developing immunity against parasites presents complex challenges due to their life cycles and antigenic diversity. Recent breakthroughs, including the approval of malaria vaccines, have revitalized the field. Researchers are exploring recombinant proteins, vector-based approaches, and adjuvant systems to boost efficacy. These vaccines offer hope for regions with limited healthcare access, where parasitic infections impose high mortality and economic strain. Continued investment and innovation in parasitic vaccines are essential to achieving sustainable control and eventual eradication of neglected parasitic diseases.
Submit your abstract Today
Title : Emerging nanovaccine strategies for enhanced immune targeting and vaccine performance
Aysel Sadayli, V.Y. Axundov Scientific-Research Institute of Medical Prophylaxis, Azerbaijan
Title : Reaching zero-dose children through adaptive immunization strategies in security-compromised areas of Zamfara State, Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria
Title : Advancing vaccine availability and equity in low-resource settings: Evidence from Awendo Sub-County, Kenya
Millicent Ochieng, Clinton Health Access Initiative, Kenya